Cited by
1. Advances in animal models of prenatal opioid exposure
2. Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport
3. Transcriptomics and metabolomics together reveal the underlying mechanism of heroin hepatotoxicity
4. Vaping Cannabinoid Acetates Leads to Ketene Formation
5. Co-occurring Disorders
6. Substance abuse and neurotransmission
7. Synthesis of Morphinans through Anodic Aryl‐Aryl Coupling
8. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
9. Oral Sensations among Individuals with Illicit Drug Dependence in Rehabilitation Centers: A Cross-Sectional Study
10. Quantitative detection of morphine based on an up-conversion luminescent system
11. DARK Classics in Chemical Neuroscience: Heroin and Desomorphine
12. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
13. Current status of opioid addiction treatment and related preclinical research
14. 6-Monoacetylmorphine (6-MAM), Not Morphine, Is Responsible for the Rapid Neural Effects Induced by Intravenous Heroin
15. The Emerging Role of Inhaled Heroin in the Opioid Epidemic
16. Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic
17. Colchicine prodrugs and codrugs: Chemistry and bioactivities
18. Food deprivation facilitates reinstatement of morphine‐induced conditioned place preference: Role of intra‐accumbal dopamine D2‐like receptors in associating reinstatement of morphine CPP with stress
19. Cognitive Improvement via mHealth for Patients Recovering from Substance Use Disorder
20. Cognitive Training through mHealth for Individuals with Substance Use Disorder
21. Site- and species-specific hydrolysis rates of heroin
22. Silane modified magnetic nanoparticles as a novel adsorbent for determination of morphine at trace levels in human hair samples by high-performance liquid chromatography with diode array detection
23. GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity
24. Computer-assisted therapy
25. Targeted Drug Delivery Systems: Strategies and Challenges
26. Opioids for pain after oral surgery
27. A new voltammetric sensor for morphine detection based on electrochemically reduced MWNTs-doped graphene oxide composite film
28. Morphine Enhances HIV-1SF162-Mediated Neuron Death and Delays Recovery of Injured Neurites
29. Increased densities of nitric oxide synthase expressing neurons in the temporal cortex and the hypothalamic paraventricular nucleus of polytoxicomanic heroin overdose victims: Possible implications for heroin neurotoxicity
30. The History of Opioid Use in Anesthetic Delivery
31. Neurotoxicity in Psychostimulant and Opiate Addiction
32. Electroencephalography and analgesics
33. Spectrofluorimetric and Spectrophotometric Analysis of Two Analgesic Drugs in Pharmaceutical Formulations and Biological Fluids
34. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis
35. Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats
36. Effects of Disulfiram on QTc Interval in Non–Opioid-Dependent and Methadone-Treated Cocaine-Dependent Patients
37. Electrocatalytic determination of morphine at the surface of a carbon paste electrode spiked with a hydroquinone derivative and carbon nanotubes
38. Prodrugs—from Serendipity to Rational Design
40. Kinetic spectrophotometric method for the determination of morphine in biological samples
41. Neurobehavioral Toxicology of Substances of Abuse
42. Post‐operative oral surgery pain: a review
43. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs
44. The chemical and pharmacological importance of morphine analogues
47. HPLC–DAD determination of opioids, cocaine and their metabolites in plasma
48. Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients
49. Synergistic increases in intracellular Ca 2+ , and the release of MCP‐1, RANTES, and IL‐6 by astrocytes treated with opiates and HIV‐1 Tat
50. Molecular targets of opiate drug abuse in neuro AIDS
51. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and ß-funaltrexamine
52. Intranasal Diamorphine as an Alternative to Intramuscular Morphine
53. Dmt and opioid peptides: A potent alliance
54. Vector-mediated drug delivery to the brain
55. μ Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine 11Abbreviations: 6-MAM, 6-monoacetylmorphine; GTPγS, guanosine-5′-O-(γ-thio)-triphosphate; DAMGO, [d-Ala2,(N-Me)Phe4,Gly5(OH)]enkephalin; M-6-G, morphine-6-βd-glucuronide; and hMOR-C6, C6 rat glioma cells expressing human μ opioid receptors.
56. Assessment of substitution in the second pharmacophore of Dmt-Tic analogues
57. Brain drug delivery technologies: novel approaches for transporting therapeutics
58. Analgesics: Opioids, Adjuvants and Others
59. Examining the Debate on the Use of Medical Marijuana
60. The role of liquid chromatography-mass spectrometry in the determination of heroin and related opioids in biological fluids
61. Anti-allodynic actions of intravenous opioids in the nerve injured rat: potential utility of heroin and dihydroetorphine against neuropathic pain
62. Pharmacology of Opiates
64. Lack of hepatocyte involvement in the genesis of the sinusoidal dilatation related to heroin addiction: a morphometric study
65. Morphine-6-glucuronide contributes to rewarding effects of opiates
66. Vascular hepatotoxicity related to heroin addiction
67. Clinical analgesic assay of repeated and single doses of heroin and hydromorphone
68. EMR and the Brain: A Brief Literature Review